We propose to continue a program of laboratory and clinical research directed at improving the results of marrow transplantation in patients with hematologic malignancies. This proposal supports investigators involved in studies aimed at improving the therapeutic potential of marrow transplantation by: (1) conducting phase I studies of new chemoradiotherapy regimens designed to have a greater anti-neoplastic effect with reduced toxicity; (2) carrying out phase III studies to define optimal regimens in large numbers of patients; (3) developing effective measures to decreasing graft-versus-host disease and thereby decreasing morbidity and mortality; (4) developing more effective methods for prevention and treatment of viral, bacterial and fungal diseases. We will investigate the extension of transplantation of marrow donors other than HLA matched siblings and the histocompatibility factors that govern success or failure. This proposal will also evaluate fundamental questions related to chimerism, origin of leukemic relapse, immunologic recovery and tolerance, in vitro hematopoiesis, monoclonal antibody application, nutritional problems, transfusion support and pulmonary and gastrointestinal complications. The pathology of graft-versus-host disease, venocclusive disease of the liver, and viral infections will be further defined including the use of molecular probes for rapid diagnosis. Biostatisticians will participate in the design and analysis of all studies. A data base management system will allow us to make maximal use of the large number of studies to be performed. Outpatient studies will define the long-term effects of marrow transplantation and will explore the feasibility of enhanced outpatient care to facilitate early discharge from hospital and thus reduce the cost of marrow transplantation.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
2P01CA018029-12
Application #
3092757
Study Section
Clinical Cancer Program Project Review Committee (CCP)
Project Start
1978-12-01
Project End
1991-11-30
Budget Start
1986-12-01
Budget End
1987-11-30
Support Year
12
Fiscal Year
1987
Total Cost
Indirect Cost
Name
Fred Hutchinson Cancer Research Center
Department
Type
DUNS #
075524595
City
Seattle
State
WA
Country
United States
Zip Code
98109
Salter, Alexander I; Pont, Margot J; Riddell, Stanley R (2018) Chimeric antigen receptor-modified T cells: CD19 and the road beyond. Blood 131:2621-2629
Lee, Stephanie J; Nguyen, Tam D; Onstad, Lynn et al. (2018) Success of Immunosuppressive Treatments in Patients with Chronic Graft-versus-Host Disease. Biol Blood Marrow Transplant 24:555-562
Bar, Merav; Flowers, Mary E D; Storer, Barry E et al. (2018) Reversal of Low Donor Chimerism after Hematopoietic Cell Transplantation Using Pentostatin and Donor Lymphocyte Infusion: A Prospective Phase II Multicenter Trial. Biol Blood Marrow Transplant 24:308-313
Armenian, Saro H; Yang, Dongyun; Teh, Jennifer Berano et al. (2018) Prediction of cardiovascular disease among hematopoietic cell transplantation survivors. Blood Adv 2:1756-1764
Petersdorf, Effie W; Stevenson, Philip; Malkki, Mari et al. (2018) Patient HLA Germline Variation and Transplant Survivorship. J Clin Oncol 36:2524-2531
Yeung, Cecilia C S; McElhone, Scott; Chen, Xue Yan et al. (2018) Impact of copy neutral loss of heterozygosity and total genome aberrations on survival in myelodysplastic syndrome. Mod Pathol 31:569-580
Lee, Stephanie J; Onstad, Lynn; Chow, Eric J et al. (2018) Patient-reported outcomes and health status associated with chronic graft-versus-host disease. Haematologica 103:1535-1541
McCune, Jeannine S; Storer, Barry; Thomas, Sushma et al. (2018) Inosine Monophosphate Dehydrogenase Pharmacogenetics in Hematopoietic Cell Transplantation Patients. Biol Blood Marrow Transplant 24:1802-1807
Deegan, Anthony J; Talebi-Liasi, Faezeh; Song, Shaozhen et al. (2018) Optical coherence tomography angiography of normal skin and inflammatory dermatologic conditions. Lasers Surg Med 50:183-193
Leger, Kasey J; Baker, K Scott; Cushing-Haugen, Kara L et al. (2018) Lifestyle factors and subsequent ischemic heart disease risk after hematopoietic cell transplantation. Cancer 124:1507-1515

Showing the most recent 10 out of 1845 publications